Cargando…
Comparison of (68)Ga-DOTANOC PET/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome
BACKGROUND: Localising ectopic adrenocorticotrophic hormone (ACTH) syndrome (EAS) tumour source is challenging. Somatostatin receptor-based PET imaging has shown promising results, but the data is limited to case reports and small case series. We reviewed here the performance of (68)Ga-DOTANOC posit...
Autores principales: | Goroshi, Majunath R, Jadhav, Swati S, Lila, Anurag R, Kasaliwal, Rajeev, Khare, Shruti, Yerawar, Chaitanya G, Hira, Priya, Phadke, Uday, Shah, Hina, Lele, Vikram R, Malhotra, Gaurav, Bandgar, Tushar, Shah, Nalini S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002954/ https://www.ncbi.nlm.nih.gov/pubmed/27006371 http://dx.doi.org/10.1530/EC-16-0010 |
Ejemplares similares
-
Gender differences in macroprolactinomas: a single centre experience
por: Khare, Shruti, et al.
Publicado: (2015) -
Bilateral adrenal masses: a single-centre experience
por: Lomte, Nilesh, et al.
Publicado: (2016) -
Incidental detection of a tumour on 68-Gallium DOTANOC PET/CT
por: Shah, Hina J., et al.
Publicado: (2014) -
Comparison of (68)Ga-DOTA-NaI(3)-Octreotide/tyr(3)-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome
por: Patil, Virendra A., et al.
Publicado: (2020) -
Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?
por: Budyal, Sweta, et al.
Publicado: (2015)